{"derived":{"adj":{"INE03QK01":[{"cum_after":1.0,"cum_from":0.5,"event_ids":["INE03QK01:2020-09-25:bonus:0"],"ex":"2020-09-25","factor":0.5,"types":["bonus"]}]},"dividends":{"bridged":false,"first_fy":"FY2020-21","fy":{"FY2020-21":{"adj":1.0,"dps":1.0,"n":1,"paid_cr":25.46,"partial":false},"FY2021-22":{"adj":4.0,"dps":4.0,"n":3,"paid_cr":101.83,"partial":false},"FY2022-23":{"adj":8.0,"dps":8.0,"n":4,"paid_cr":203.66,"partial":false}},"fy_dps":null,"fy_last":"FY2025-26","fy_paid_cr":null,"held":0,"last_ex":"2022-09-09","open":true,"paid_ttm_cr":null,"payouts":8,"raised":0,"shares_asof":"2026-09-30","shares_out":382542268,"since":"FY2020-21","streak":0,"streak_ended":3,"ttm_dps":null,"ttm_n":0,"ttm_partial":false,"years_on_record":3,"yield_fy":null,"yield_ttm":null},"dividends_by_fy":{"INE03QK01":{"FY2020-21":{"distribution":0.0,"final":0.0,"interim":1.0,"n":1,"pct_only":0,"special":0.0,"total":1.0,"unspecified":0.0},"FY2021-22":{"distribution":0.0,"final":1.0,"interim":1.0,"n":3,"pct_only":0,"special":2.0,"total":4.0,"unspecified":0.0},"FY2022-23":{"distribution":0.0,"final":0.0,"interim":2.0,"n":4,"pct_only":0,"special":6.0,"total":8.0,"unspecified":0.0}}}},"events":[{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"1:1","event_id":"INE03QK01:2020-09-25:bonus:0","ex":"2020-09-25","ex_move":{"factor":0.5,"move":3.89,"on":["2020-09-25",383.7],"pre":["2020-09-24",738.7]},"exchanges":["BSE","NSE"],"field_provenance":{"adj_factor":"nse_pr_bc","bonus_den":"nse_pr_bc","bonus_num":"nse_pr_bc"},"fields":{"adj_factor":0.5,"bonus_den":1,"bonus_num":1},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2020-09-21","nd_to":"2020-09-25","payment":null,"price_adjust":true,"qtychange":true,"raw":[{"ex_from_record":false,"first_seen":"2020-09-18","last_seen":"2020-09-25","purpose":"BONUS 1:1","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2020-09-18","last_seen":"2020-09-25","purpose":"BONUS 1:1","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Bonus 1:1","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Bonus issue 1:1","scrip":"543064","series":null,"src":"bse_dd","symbol":null}],"record":"2020-09-28","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":null,"symbol":"SUVENPHAR","type":"bonus"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 1 per share","event_id":"INE03QK01:2021-02-17:dividend:0","ex":"2021-02-17","ex_move":{"move":-1.27,"on":["2021-02-17",494.3],"pre":["2021-02-16",500.65]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":1.0,"payout_cr":25.46},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2021-02-11","nd_to":"2021-02-16","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2021-02-11","last_seen":"2021-02-17","purpose":"INT DIV - RE 1 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2021-02-11","last_seen":"2021-02-17","purpose":"INT DIV - RE 1 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Re 1  Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Interim Dividend - Rs. - 1.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null}],"record":"2021-02-18","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"interim","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 1 per share","event_id":"INE03QK01:2021-08-13:dividend:0","ex":"2021-08-13","ex_move":{"move":0.09,"on":["2021-08-13",542.95],"pre":["2021-08-12",542.45]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":1.0,"payout_cr":25.46},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2021-08-10","nd_to":"2021-08-16","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2021-06-29","last_seen":"2021-08-16","purpose":"AGM/DIV - RE 1 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2021-06-29","last_seen":"2021-08-16","purpose":"AGM/DIV - RE 1 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend - Re 1 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Final Dividend - Rs. - 1.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null}],"record":"2021-08-17","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"final","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":null,"class":"equity","confidence":1.0,"detail":"","event_id":"INE03QK01:2021-08-13:meeting:0","ex":"2021-08-13","exchanges":["NSE"],"field_provenance":{},"fields":{},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2021-06-29","last_seen":"2021-08-16","purpose":"AGM/DIV - RE 1 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2021-06-29","last_seen":"2021-08-16","purpose":"AGM/DIV - RE 1 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend - Re 1 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"}],"record":"2021-08-17","series":"BE","sources":["nse_pr_bc","nse_api"],"subtype":"agm","symbol":"SUVENPHAR","type":"meeting"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 1 per share","event_id":"INE03QK01:2022-02-15:dividend:0","ex":"2022-02-15","ex_move":{"move":5.29,"on":["2022-02-15",523.1],"pre":["2022-02-14",496.8]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":1.0,"payout_cr":25.46},"flags":["restated"],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2022-02-09","nd_to":"2022-02-15","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-02-03","last_seen":"2022-02-08","purpose":"INTERIM DIVIDEND","restated":true,"scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-02-03","last_seen":"2022-02-08","purpose":"INTERIM DIVIDEND","restated":true,"scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-02-09","last_seen":"2022-02-15","purpose":"INTDIV-RE 1/SPLDIV-RS 2","restated":true,"scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-02-09","last_seen":"2022-02-15","purpose":"INTDIV-RE 1/SPLDIV-RS 2","restated":false,"scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Re 1 Per Share/ Special Dividend - Rs 2 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Interim Dividend - Rs. - 1.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null}],"record":"2022-02-16","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"interim","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 2 per share","event_id":"INE03QK01:2022-02-15:dividend:1","ex":"2022-02-15","ex_move":{"move":5.29,"on":["2022-02-15",523.1],"pre":["2022-02-14",496.8]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":2.0,"payout_cr":50.91},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2022-02-09","nd_to":"2022-02-15","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-02-09","last_seen":"2022-02-15","purpose":"INTDIV-RE 1/SPLDIV-RS 2","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-02-09","last_seen":"2022-02-15","purpose":"INTDIV-RE 1/SPLDIV-RS 2","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Re 1 Per Share/ Special Dividend - Rs 2 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Special Dividend - Rs. - 2.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null}],"record":"2022-02-16","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"special","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 1 per share","event_id":"INE03QK01:2022-05-13:dividend:0","ex":"2022-05-13","ex_move":{"move":1.09,"on":["2022-05-13",521.6],"pre":["2022-05-12",516.0]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":1.0,"payout_cr":25.46},"flags":["restated"],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2022-05-10","nd_to":"2022-05-16","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-05-05","last_seen":"2022-05-09","purpose":"INTERIM DIVIDEND","restated":true,"scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-05-05","last_seen":"2022-05-09","purpose":"INTERIM DIVIDEND","restated":true,"scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-05-10","last_seen":"2022-05-16","purpose":"INTDIV-RE 1/SPLDIV- RE 1","restated":true,"scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-05-10","last_seen":"2022-05-16","purpose":"INTDIV-RE 1/SPLDIV- RE 1","restated":false,"scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Interim Dividend - Rs. - 1.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null}],"record":"2022-05-17","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"interim","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 1 per share","event_id":"INE03QK01:2022-05-13:dividend:1","ex":"2022-05-13","ex_move":{"move":1.09,"on":["2022-05-13",521.6],"pre":["2022-05-12",516.0]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":1.0,"payout_cr":25.46},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2022-05-10","nd_to":"2022-05-16","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-05-10","last_seen":"2022-05-16","purpose":"INTDIV-RE 1/SPLDIV- RE 1","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-05-10","last_seen":"2022-05-16","purpose":"INTDIV-RE 1/SPLDIV- RE 1","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Special Dividend - Rs. - 1.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null}],"record":"2022-05-17","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"special","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":"2022-08-16","bc_to":"2022-08-18","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"","event_id":"INE03QK01:2022-08-11:meeting:0","ex":"2022-08-11","exchanges":["NSE"],"field_provenance":{},"fields":{},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-07-07","last_seen":"2022-08-17","purpose":"ANNUAL GENERAL MEETING","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-07-07","last_seen":"2022-08-17","purpose":"ANNUAL GENERAL MEETING","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api"],"subtype":"agm","symbol":"SUVENPHAR","type":"meeting"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 1 per share","event_id":"INE03QK01:2022-09-09:dividend:0","ex":"2022-09-09","ex_move":{"move":-2.88,"on":["2022-09-09",477.4],"pre":["2022-09-08",491.55]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc","div_pct_fv":"bse_corpact","fv_used":"bse_corpact"},"fields":{"div_amount":1.0,"div_pct_fv":100.0,"fv_used":1.0,"payout_cr":25.46},"flags":["bse_code_amount_conflict","fv_assumed_current","fv_from_counterpart"],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2022-09-05","nd_to":"2022-09-09","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-09-05","last_seen":"2022-09-09","purpose":"INTDIV-RE 1/SPLDIV-RS 5","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-09-05","last_seen":"2022-09-09","purpose":"INTDIV-RE 1/SPLDIV-RS 5","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Interim Dividend - Rs. - 1.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-17","last_seen":"2026-11-11","purpose":"DP-100%,DP-500%","scrip":"543064","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"DP-100%,DP-500%","scrip":"543064","series":null,"src":"bse_corpact","symbol":null}],"record":"2022-09-12","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","bse_corpact"],"subtype":"interim","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Rs 5 per share","event_id":"INE03QK01:2022-09-09:dividend:1","ex":"2022-09-09","ex_move":{"move":-2.88,"on":["2022-09-09",477.4],"pre":["2022-09-08",491.55]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc","div_pct_fv":"bse_corpact","fv_used":"bse_corpact"},"fields":{"div_amount":5.0,"div_pct_fv":100.0,"fv_used":1.0,"payout_cr":127.28},"flags":["fv_assumed_current","fv_from_counterpart"],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":"2022-09-05","nd_to":"2022-09-09","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-09-05","last_seen":"2022-09-09","purpose":"INTDIV-RE 1/SPLDIV-RS 5","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2022-09-05","last_seen":"2022-09-09","purpose":"INTDIV-RE 1/SPLDIV-RS 5","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-11-12","last_seen":"2026-11-12","purpose":"Special Dividend - Rs. - 5.0000","scrip":"543064","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-17","last_seen":"2026-11-11","purpose":"DP-100%,DP-500%","scrip":"543064","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"DP-100%,DP-500%","scrip":"543064","series":null,"src":"bse_corpact","symbol":null}],"record":"2022-09-12","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","bse_corpact"],"subtype":"special","symbol":"SUVENPHAR","type":"dividend"},{"announce":null,"bc_from":"2023-12-13","bc_to":"2023-12-15","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"","event_id":"INE03QK01:2023-12-12:meeting:0","ex":"2023-12-12","exchanges":["MSE","NSE"],"field_provenance":{},"fields":{},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2023-12-01","last_seen":"2023-12-15","purpose":"ANNUAL GENERAL MEETING","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2023-12-01","last_seen":"2023-12-15","purpose":"ANNUAL GENERAL MEETING","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"COHANCE","purpose":"AGM","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2023-12-12","series":"BE","sources":["nse_pr_bc","nse_api","mse_ca"],"subtype":"agm","symbol":"SUVENPHAR","type":"meeting"},{"announce":null,"bc_from":"2024-08-07","bc_to":"2024-08-09","bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"","event_id":"INE03QK01:2024-08-06:meeting:0","ex":"2024-08-06","exchanges":["BSE","NSE"],"field_provenance":{},"fields":{},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2024-08-05","last_seen":"2024-08-09","purpose":"ANNUAL GENERAL MEETING","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":"2024-08-05","last_seen":"2024-08-09","purpose":"ANNUAL GENERAL MEETING","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"SUVENPHAR"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting","scrip":null,"series":"EQ","src":"nse_api","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"AGM","scrip":"543064","series":null,"src":"bse_corpact","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_corpact"],"subtype":"agm","symbol":"SUVENPHAR","type":"meeting"},{"announce":"2026-10-26","bc_from":null,"bc_to":null,"bse_scrip":"543064","class":"equity","confidence":1.0,"detail":"Financial results for the period ended Sep 2026","event_id":"INE03QK01:2026-11-06:meeting:0","ex":"2026-11-06","exchanges":["BSE","NSE"],"field_provenance":{"agenda":"nse_bm","attachment":"nse_bm","period":"nse_bm"},"fields":{"agenda":["results"],"attachment":"https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_17775_WebXMLFile_20261026_181859117.xml","period":"2026-09"},"flags":[],"group":"equity","instrument_id":"INE03QK01018","isin_after":null,"isin_at_event":"INE03QK01018","issuer_id":"INE03QK","lineage":"INE03QK01","name":"Cohance Lifesciences Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-10-26","last_seen":"2026-11-12","purpose":"BOARD MEETING: Board Meeting Intimation | Cohance Lifesciences Limited has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .","scrip":null,"series":"EQ","src":"nse_bm","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-10-26","last_seen":"2026-11-12","purpose":"BOARD MEETING: Financial Results | To consider and approve the financial results for the period ended September 30, 2026","scrip":null,"series":"EQ","src":"nse_bm","symbol":"COHANCE"},{"ex_from_record":false,"first_seen":"2026-10-27","last_seen":"2026-11-12","purpose":"BOARD MEETING: Quarterly Results","scrip":"543064","series":null,"src":"bse_bm","symbol":null}],"record":null,"series":"EQ","sources":["nse_bm","bse_bm"],"subtype":"board","symbol":"COHANCE","type":"meeting"}],"instruments":[{"bse":["143064"],"class":"equity","coupon_pct":null,"coupon_src":null,"frequency":null,"isin":"INE03QK01018","last_event":"2026-11-06","maturity":null,"n_events":14,"name":"Cohance Lifesciences Limited","next_event":null,"nse":["COHANCE"],"status":"listed","symbol":"COHANCE","ticker":"COHANCE"}],"issuer":{"bse_scrips":["543064","143064"],"bse_tickers":["COHANCE"],"classes":{"equity":1},"delisted_on":null,"equity_isins":["INE03QK01018"],"file":"INE03QK","first_year":"2020","industry":"Pharmaceuticals & Biotechnology","issuer_id":"INE03QK","last_seen":"2026-11-12","last_year":"2026","mse_listed":false,"mse_symbols":["COHANCE"],"n_events":14,"n_instruments":1,"name":"Cohance Lifesciences Limited","names":["Cohance Lifesciences Limited"],"next_ex":null,"nse_symbols":["COHANCE","SUVENPHAR"],"px":true,"sector":"Healthcare","slug":"COHANCE","status":"listed"}}